ICHP 2017 Annual Meeting logo

The Illinois Council of Health-System Pharmacists (ICHP) adopts the ASHP position statements 9801 COLLABORATIVE DRUG THERAPY MANAGEMENT ACTIVITIES and 1213 PHARMACIST PRESCRIBING IN INTERPROFESSIONAL PATIENT CARE.

Key portions of these statements include:

“To support the participation of pharmacists in collaborative drug therapy management, which is defined as a multidisciplinary process for selecting appropriate drug therapies, educating patients, and continually assessing outcomes of therapy; further,

To recognize that pharmacists participate in collaborative drug therapy management for a patient who has a confirmed diagnosis by an authorized prescriber: further,

To recognize that the activities of a pharmacist in collaborative drug therapy management may include but not be limited to, initiating, modifying, and monitoring a patient’s drug therapy; ordering and performing laboratory and related tests; assessing patient response to therapy; counseling and educating a patient on medications; and administering medications.¹

“To define pharmacist prescribing as follows: patient assessment and the selection, initiation, monitoring, adjustment, and discontinuation of medication therapy pursuant to diagnosis of a medical disease or condition.²
 
“To advocate that health care delivery organizations establish credentialing and privileging processes that delineate the scope of pharmacist prescribing within the hospitals or health-systems and to ensure that pharmacists who prescribe are competent and qualified to do so.”²

¹ ASHP Policy Position 9801 COLLABORATIVE DRUG THERAPY MANAGEMENT ACTIVITIES

² ASHP Policy Position 1213 PHARMACIST PRESCRIBING IN INTERPROFESSIONAL PATIENT CARE


Revised 10/2015